Uslaner_2018_J.Pharmacol.Exp.Ther_365_556

Reference

Title : Preclinical to Human Translational Pharmacology of the Novel M1 Positive Allosteric Modulator MK-7622 - Uslaner_2018_J.Pharmacol.Exp.Ther_365_556
Author(s) : Uslaner JM , Kuduk SD , Wittmann M , Lange HS , Fox SV , Min C , Pajkovic N , Harris D , Cilissen C , Mahon C , Mostoller K , Warrington S , Beshore DC
Ref : Journal of Pharmacology & Experimental Therapeutics , 365 :556 , 2018
Abstract : Uslaner_2018_J.Pharmacol.Exp.Ther_365_556
ESTHER : Uslaner_2018_J.Pharmacol.Exp.Ther_365_556
PubMedSearch : Uslaner_2018_J.Pharmacol.Exp.Ther_365_556
PubMedID: 29563325

Related information

Citations formats

Uslaner JM, Kuduk SD, Wittmann M, Lange HS, Fox SV, Min C, Pajkovic N, Harris D, Cilissen C, Mahon C, Mostoller K, Warrington S, Beshore DC (2018)
Preclinical to Human Translational Pharmacology of the Novel M1 Positive Allosteric Modulator MK-7622
Journal of Pharmacology & Experimental Therapeutics 365 :556

Uslaner JM, Kuduk SD, Wittmann M, Lange HS, Fox SV, Min C, Pajkovic N, Harris D, Cilissen C, Mahon C, Mostoller K, Warrington S, Beshore DC (2018)
Journal of Pharmacology & Experimental Therapeutics 365 :556